Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions

Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions

US Patent 9980970 · Granted May 29, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functiona2019
Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functiona2019
Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functiona2019
Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,2017
Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,2016
Combination of a slow sodium current blocker and a sinus If current inhibitor, a2016
Derivatives of benzothiazines, preparation thereof and application thereof as dr2015
Nitrogen heterocycle derivatives, preparation thereof and application thereof in2015
Derivatives of 2H pyridazin-3-ones, their preparation and their use as SCD-1 inh2015
Derivatives of triazines and uracils, their preparation and their application in2013
Cinnamoyl-piperazine derivatives and their use as par-1 antagonists2013
Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists2012